THE CHOSEN ONES.
Meet the three teams that progress to the next stage of the Internet-of-Ingestible-Things™ Hackathon as they begin to prototype their gut sensing pills.
The Internet-of-Ingestible-Things™ Series
As co-founder of Enteromics and PhD in Cyber-biosecurity, I launch the very first Internet-of-Ingestible-Things™ Hackathon, sponsored by the Dawes Centre for Future Crime, as a series of workshops bringing together experts from cybersecurity with medical device regulatory bodies and makers, to help design security for the new generation “Ingestible-Things”™ or secure smart gut-sensing pills.
We have selected the Top three teams from a competitive round of seven other applicant groups with a very high standard of proposals. The selected teams will progress into the next stage of the Internet-of-Ingestible-Things™ (#IoiTHack) to help design and build the new generation of secure smart gut sensing pills. Although a tough competition with varying smart pill designs and applications — the Top 3 were selected according to the following criteria with a focus on security design:
- Originality of thought — 40%
- Credibility and relevance of topic — 40%
- Use of real world case studies — 20%
Ready to meet the teams of the Internet-of-Ingestible-Things™ ?
SmarTrace, for every cruise case.
A Neuroscientist, a multi-award winning pharmacist and a NextGenTech Growth Manager are tackling a very timely issue: norovirus outbreak control — on ships!
The SmarTrace team focuses on a niche but extremely challenging problem of tracing highly contagious infections such as the Norovirus, on cruise ships during quarantine.
Despite lockdown and additional measures implemented in the last year while facing COVID19, major cruise liners have reported a failure to successfully control the virus as over 11% of their passengers were infected.
The SmarTrace team is uniquely introducing a private blockchain to their proposed solution for secure and transparent data transmission — follow them as they take a deeper dive on the design for their Ingestible-Things™ device that will allow for rapid identification of infected individuals.
Power to the patient with BiotAI.
What’s had a 290% increase in the last 5 years? Gut Health Research.
Yet it is difficult to get a full picture of the “gut microbiome” — or ecosystem of microorganisms that reside in your gut and are responsible for your digestion and health — due to limitations with methods in accessing and analysing the gut.
With the race to understand the ‘perfect’ gut microbiome, the BiotAI team is on a mission to provide an easy-to-use Ingestible-Things™ device, jumping on the new consumer trend to track one’s body by giving power to the patient.
10–15% of the worldwide population is estimated to suffer from some gastrointestinal issue, keep track of BiotAI as they cater for a rapid but secure cloud communication system.
Inflammation: Locate and Deactivate.
What happens when an Electronic Engineer, a Medical and Management strategist and a Computational Mathematician meet? IBDeactivate is born: a team proposing an Ingestible-Things™ device for targeted drug release, while addressing security and privacy concerns of patients and clinicians.
More than 3 million people in the USA and Europe have inflammatory bowel disease (IBD), a chronic condition of inflammation in gut that can cause various symptoms from severe abdominal pain to bleeding and surgery.
IBDeactivate team has specialist skills in embedded systems for IoT, and will be prototyping an Ingestible-Things™ device design for targeted micro-dosing of anti-inflammatory drugs in the gut but with firmware coding and telecommunication security needs for clinical and patient acceptance. Follow their journey in addressing key privacy questions such as are medical practitioners confident enough to supply Ingestible-Things™ devices to patients? Are patients comfortable with ingesting an Ingestible-Things™ device?
What’s next for the three teams?
A month’s sprint of some real prototyping.
The teams will learn how to design their Ingestible-Things™ devices through one-to-one workshops with our partners, the Institute of Making and Enteromics ltd. As they prototype their designs, the teams will assess their devices for security design through red-teaming sessions with BioBright and Security-by-Design Think Tanks sessions with the Dawes Centre for Future Crime.
Finally, the teams will be expected to produced a 2-minute video pitching their Ingestible-Things™ devices in a “demo battle” in June.
Tune-in as they will need your vote for a chance to win a cash prize of £1000 — sponsored by the Dawes Centre for Future Crime!
INTERNET-OF-INGESTIBLE-THINGS™: WHY NOW?
Watch a 3-min video explaining why we have launched the very first Internet-of-Ingestible-Things™ series!
WATCH HERE: https://lnkd.in/dMgXd5X
Were you eager to take part in the Internet-of-Ingestible-Things #IoiTHack but didn’t get a chance to this year?
Fill in this quick form to be the first to know for the next one! https://vcx1vh0xjld.typeform.com/to/Zmw7ZuB1
Are you a professional within the digital biosecurity or cyber-biosecurity space? Do you want to keep track of news, events and developments within the community?
Join our network here: https://vcx1vh0xjld.typeform.com/to/W4NOEzXN
The Internet-of-Ingestible-Things™ series and hackathon is led by Mariam Elgabry, Co-founder and Director of Enteromics, a MedTech start-up that builds smart gut-sensing pills that once swallowed connect to a smart phone via an App to deliver AI-powered gut health insights; moving healthcare to the comfort of the home.
Mariam’s background is in deep-tech and bioengineering, holding a MSc in Bioinformatics & Theoretical Systems Biology from Imperial College London, as well as a MRes in Security & Crime Science from the University College London (UCL). Alongside her role at Enteromics, she researches Bio-crime, the Internet-of-Medical-Things (IoMT), and Cyber-biosecurity as part of her PhD research at the Dawes Centre for Future Crime, UCL. Her most recent work discusses the COVID-19 pandemic and its effect on Cyber-biosecurity in the UK and abroad; published by the UK Parliament Joint Committee on National Security.
Mariam’s experience lies at the intersection of industry and research, focusing on tech, health and security. At AstraZeneca, She led an award winning technology for early detection systems in drug testing. Later, as a Lead Microsoft Student Partner, she had the opportunity to help translate technology and innovative tools, from hackathons into start-ups. Alongside her studying, her work as a Sergeant at the London Metropolitan Police exposed her to operations on the field, including risk mitigation — from managing policing activity, to effective deployment of resources to incidents; skills later applied in her work as a Security Design Consultant.